| Date Filed | Type | Description |
| 10/10/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/02/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/10/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/25/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/11/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/24/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/24/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/29/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/08/2023 |
8-K
| Other Events Interactive Data |
| 02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 1.3% stake in THIRD HARMONIC BIO, INC. |
| 02/14/2023 |
SC 13G/A
| Bain Capital Life Sciences Investors, LLC reports a 2.8% stake in Third Harmonic Bio, Inc. |
| 02/08/2023 |
SC 13G
| Novartis Institutes for BioMedical Research, Inc. reports a 6.5% stake in Third Harmonic Bio, Inc. |
| 01/19/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/21/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10.8% stake in Third Harmonic Bio, Inc. |
| 12/21/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 11/09/2022 |
8-K
| Quarterly results |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/25/2022 |
8-K
| Quarterly results |
| 10/11/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/29/2022 |
SC 13G
| Bain Capital Life Sciences Investors, LLC reports a 5.7% stake in Third Harmonic Bio, Inc. |
| 09/29/2022 |
SC 13D
| Atlas Venture Fund XI, L.P. reports a 25.6% stake in THIRD HARMONIC BIO, INC. |
| 09/28/2022 |
SC 13D
| ORBIMED ADVISORS LLC reports a 14.3% stake in Third Harmonic Bio, Inc. |
| 09/28/2022 |
SC 13D
| GENERAL ATLANTIC, L.P. reports a 7.3% stake in Third Harmonic Bio, Inc. |
| 09/26/2022 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 9.1% stake in Third Harmonic Bio, Inc. |
| 09/26/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 8.6% stake in THIRD HARMONIC BIO, INC. |
| 09/15/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 09/15/2022 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 09/15/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|